Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders

NCT02456545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1419

Last updated 2024-08-07

No results posted yet for this study

Summary

Prospective multicentre observational study for treatment approaches in at-risk individuals. Furthermore the purpose of this study is to test feasibility of a clinical staging model and validate diagnostic tools to identify individuals at risk state for the development of BD.

Conditions

Interventions

OTHER

≥ 1 potential risk factor for BD

exposure to ≥ 1 potential risk factors for BD (e.g. (sub)threshold affective symptomatology, anxiety, sleep disturbances, family history, episodic substance misuse)

OTHER

depressive syndrome

in- and outpatients with depressive syndrome

OTHER

ADHD

in- and outpatients with ADHD

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV
  • Charite University, Berlin, Germany

    collaborator OTHER
  • Ruhr University of Bochum

    collaborator OTHER
  • Goethe University

    collaborator OTHER
  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • Philipps University Marburg

    collaborator OTHER
  • University Hospital Tuebingen

    collaborator OTHER
  • Vivantes Hospital am Urban, Berlin

    collaborator UNKNOWN
  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Andrea Pfennig, Dr. med. · University Hospital Dresden, Technische Universität Dresden

  • Michael Bauer, Dr. rer. nat. · University Hospital Dresden, Technische Universität Dresden

  • Martin Lambert, Dr. med. · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-03
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02456545 on ClinicalTrials.gov